Eastern Mediterranean (WHO region) vs Mauritius: Treatment success rate for patients treated for MDR-TB
Eastern Mediterranean (WHO region)
75.0%
in 2022
Mauritius
100.0%
in 2022
Eastern Mediterranean (WHO region) rank
4th
Mauritius rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Eastern Mediterranean (WHO region)
- Mauritius
How they compare
Mauritius currently reports 100.0% against 75.0% in Eastern Mediterranean (WHO region), a difference of 25.0%.
That makes Mauritius's figure about 1.3 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 8 times across 14 shared years of data; in 2006 it was Mauritius ahead.
Eastern Mediterranean (WHO region) ranks 4th and Mauritius ranks 1st of 11 groups.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.8% | 87.5% | 38.8% | Mauritius |
| 2010s | 64.6% | 64.6% | 0.0% | — |
| 2020s | 74.5% | 75.0% | 0.5% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Eastern Mediterranean (WHO region) or Mauritius?
- Mauritius, at 100.0% against 75.0% in Eastern Mediterranean (WHO region) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Eastern Mediterranean (WHO region) and Mauritius?
- 25.0%, with Mauritius ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Mauritius?
- 14 years are reported by both, from 2006 to 2022.
- How do Eastern Mediterranean (WHO region) and Mauritius rank globally for treatment success rate for patients treated for mdr-tb?
- Eastern Mediterranean (WHO region) ranks 4th and Mauritius ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.